Amid public uproar, FDA mulls risk upgrade for controversial pelvic mesh

FDA regulators consider ramping up regulatory oversight of pelvic organ prolapse devices amid the ongoing public din over the dangers to women.

The FDA today issued a pair of proposed orders that would increase regulatory oversight of controversial pelvic mesh products, responding to a long-running public uproar about the implants' potential for harm to women.

Boston Scientific, C.R. Bard, Ethicon Inc., Food & Drug Administration (FDA), Johnson & Johnson

News Well, Food & Drug Administration (FDA), Gynecological, Regulatory/Compliance, Women's Health

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mWwYw5